Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
about
Phage therapy: concept to cureBacteriophage therapyPhage therapy of Pseudomonas aeruginosa infection in a mouse burn wound modelPhage therapy of pulmonary infectionsEcology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm BacteriaPseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administrationIsolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease controlPhage treatment of human infections.Long-circulating bacteriophage as antibacterial agentsUsing bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages.Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in miceEnhancing and initiating phage-based therapies.Phage Therapy - Everything Old is New AgainRecent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteriaAntibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster.Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool.Phage therapy: eco-physiological pharmacology.'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material.Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.Antagonistic Microbial Interactions: Contributions and Potential Applications for Controlling Pathogens in the Aquatic Systems.Hydrolytic activity determination of Tail Tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.Prospects for Biocontrol of Vibrio parahaemolyticus Contamination in Blue Mussels (Mytilus edulus)-A Year-Long Study.The disparate effects of bacteriophages on antibiotic-resistant bacteria
P2860
Q21131139-655A1161-CEF2-4181-A47A-7D0F8818FD37Q24550616-51BB3831-65F6-444E-A76E-F0C1EFD7FCD6Q24673374-5B5FCFBD-8AFF-47A8-AAB2-6E97CE9400C1Q26781119-4B1AC5E1-362F-4691-A7CD-823320F1DBF3Q26786947-13138B16-5E93-433C-B38A-83EF2C45B4DBQ28484466-A9194DBC-A541-4883-ACA3-6C36A820D0D1Q33986903-6155EBC7-BDD4-477E-A750-748CA56F880FQ34254407-5DE869A7-2BCF-4587-991A-4245ECA77111Q34378378-98876829-117C-45DD-9397-0A9099F89245Q34506458-75A11082-0559-4BC4-8EB2-B3A622086C3FQ35210425-D7BA656D-8DB3-4168-9F6A-3CB25D8C2673Q35635891-D97C4A16-6584-4813-B8C4-16EF143E8080Q36105880-9E83596A-62A0-4453-8546-F0F901BF32E6Q36171271-EE654073-6530-477B-89C9-0B5A2888519FQ36341673-CDC6991B-3695-48D5-851A-B0614DDA8BAAQ36364160-1D98E6D6-A791-4A31-8DDE-928D56ADFD22Q36571896-A8C9C971-CA2F-4465-8BE0-97340EFE5545Q36652581-C30CE5CA-79C2-43E2-B95B-7B15090A2785Q37204120-BB00A767-3CB2-4546-A161-ECA66EFAF625Q37629864-30C5FAD1-EC63-4131-A029-D899E8423F2CQ38131268-A287D4E7-175A-46BC-81D1-BC974DBB1CE9Q38225652-D4E1BECA-0787-4B3F-985F-0A277619968DQ38230407-C8F5936B-1EA0-4AAA-94BB-CFB6BCD33410Q39388122-6C221094-AAF5-43C2-933D-2AD722802016Q39552106-CFBFE167-430C-4B5A-981B-99FA07826FE4Q41953340-843510F9-8E82-47CD-A3BF-89C0935C136DQ46201519-54023C87-3F2B-4AFD-B7BD-CF44C570738BQ47118120-38B54E22-1A53-4C0E-A60D-7EAEDF75D69FQ47120147-CF9371B0-D067-4F2D-A449-2388781A8630Q49631079-CA5EEA3B-A35E-4070-BFCF-D6B0888A0207Q50041908-01F8B721-4260-421F-A535-EC9DEE8EFFC7Q55209399-24C249E8-2AF2-4912-9D64-EA9677BE907DQ57283588-AD5C1363-08AF-46E5-948E-D7A09A44DC10
P2860
Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@ast
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@en
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@nl
type
label
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@ast
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@en
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@nl
prefLabel
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@ast
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@en
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@nl
P2093
P1476
Results of bacteriophage treat ...... ctions in the years 1981-1986.
@en
P2093
Dabrowski M
Kucharewicz-Krukowska A
Weber-Dabrowska B
P304
P577
1987-01-01T00:00:00Z